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Objectives.T oe v a l u a t et h ein vitro leishmanicidal activity of nine ﬂavonoid derivatives from Delphinium staphisagria against
L. infantum and L. braziliensis. Design and Methods.T h ein vitro activity of compounds 1–9 was assayed on extracellular
promastigote and axenic amastigote forms and on intracellular amastigote forms of the parasites. Infectivity and cytotoxicity
tests were carried on J774.2 macrophage cells using Glucantime as the reference drug. The mechanisms of action were analysed
performingmetaboliteexcretionandtransmissionelectronicmicroscopeultrastructuralalterationstudies.Results.Nineﬂavonoids
showed leishmanicidal activity against promastigote as well as amastigote forms of Leishmania infantum and L. braziliensis.T h e s e
compoundswerenontoxictomammaliancellsandwereeﬀectiveatsimilarconcentrationsuptoorlowerthanthatofthereference
drug (Glucantime). The results showed that 2
  -acetylpetiolaroside (compound 8) was clearly the most active. Conclusion. This
study has demonstrated that ﬂavonoid derivatives are active against L. infantum and L. braziliensis.
1.Introduction
Leishmaniasis is an infection caused by diﬀerent species of
the protozoan genus Leishmania, which is transmitted by
dipterans of the genera Phlebotomus in the Old World and
Lutzomyia in the New World.
Leishmaniasis represents one of the most signiﬁcant of
a collection of neglected tropical diseases. According to the
latest report of the World Health Organization [1], 350
million people in 88 countries are considered at risk of con-
tracting leishmaniasis, and some 2 million new cases occur
annually.
Drug treatment for leishmaniasis has been available since
the beginning of the 20th Century [1], but only a few
drugs have been developed for use and there are numerous
drawbacks to each of the treatments. Two pentavalent
antimonials are available (meglumine antimoniate or Glu-
cantime and sodium stibogluconate or pentostan), but they
havecommonsideeﬀectssuchasanorexia,vomiting,nausea,
abdominal pain, malaise, and myalgia. They are available in
several formulations, which are administered by intravenous
infusion, including liposomal amphotericin B, amphotericin
B lipid complex, and amphotericin B colloidal dispersion.
However, side eﬀects such as fever, chills, rigor and back
pain, and transient nephrotoxicity or thrombocytopenia
occur in some patients. Other antileishmanial medicines
are paromomycin (aminosidine) and pentamidine isethion-
ate, which are usually administered intramuscularly. The
alkyl phospholipid (hexadecylphosphocholine), commonly
known as miltefosine, induces gastrointestinal side eﬀects
such as anorexia, nausea, vomiting (38%) and diarrhea
(20%), and also skin allergies, elevated hepatic transaminase
concentrations,and,occasionally,renalfailure.Itisnowused
in combination with diﬀerent classes of azole oral antifungal
agentsincludingketoconazole,ﬂuconazole,anditraconazole.
In addition to the adverse eﬀects of the drugs, resistance
to these treatments is appearing in the parasites. For all these2 The Scientiﬁc World Journal
reasons, further novel drug development is necessary to treat
these infections.
Considerable attention is currently being paid to phy-
totherapy in the search for new drugs. One method used
to discover new drugs is to investigate natural products
from plants used medicinally [2] .T h eb r o a dr a n g eo fp l a n t
families and species available oﬀers many potentially active
leishmanicidal substances [3, 4]. Leishmanicidal capacity of
alkaloid compounds isolated from medicinal plants has been
studied [5], and the antileishmania capacity of Aloe Vera
exudate against L. donovani has been established [6].
Leishmanicidal properties may reside in phytochemicals
such as ﬂavonoids, which are hence strong candidates for use
in combination therapy against these infections. Flavonoids
are abundant in fruits, vegetables, and saps of plants and
are demonstrated to have anticarcinogenic, antimicrobial,
and antiparasitic activity [7, 8]. Flavonoid analogues derived
from Consolida oliveriana exerted a signiﬁcant eﬀect on the
in vitro growth of species of Leishmania spp. [9].
In this work, the inhibitory eﬀects of ﬂavonoids from
aerial parts of Delphinium staphisagria L. (Ranunculaceae)
on the extracellular and intracellular stages of L. infantum
and L. braziliensis were investigated. In addition, the cyto-
toxic eﬀects of these compounds against a host cell line
were assessed. We also used 1H-NMR spectroscopic analysis
to determine the nature and percentage of the excretion
metabolites and to elucidate any inhibitory eﬀect that the
compounds have on the glycolytic pathway. Finally, the
eﬀects of the compounds on the ultrastructure were studied.
2.MaterialandMethods
2.1. Plant Material. Aerial parts of the Delphinium staphis-
agria were collected and processed as described previously
D´ ıaz et al. [10]. Nine ﬂavonoids (1–9) were isolated,
derivatized, and identiﬁed (Figure 1)[ 10].
2.2. Parasite Strain and Culture. L. infantum (MCAN/ES/
2001/UCM-10) and L. braziliensis (MHOM/BR/1975/
M2904) were cultivated in vitro in trypanosomes liquid
medium (MTL) with 10% inactive fetal bovine serum and
were kept in an air atmosphere at 28◦C, in Roux ﬂasks
(Corning, USA) with a surface area of 75cm2, according to
the methodology described by Gonz´ alez et al. [4].
2.3. Cell Culture and Cytotoxicity Tests. J774.2 macrophages
(ECACC number 91051511) were originally obtained from a
tumour in a female BALB/c rat in 1968. The cytotoxicity test
for macrophages was performed according to the method-
ology of Gonz´ alez et al. [4]. After 72 hours of treatment,
cell viability was determined by ﬂow cytometry. Thus,
100μL/well of propidium iodide solution (100mg/mL) was
added and incubated for 10min at 28◦C in darkness. After-
wards, 100μL/well of ﬂuorescein diacetate (100ng/mL) was
added and incubated under the same conditions. Finally, the
cellswere recovered by centrifugationat 400g for10min and
the precipitate washed with phosphate buﬀered saline (PBS).
FlowcytometricanalysiswasperformedwithaFACSVantage
ﬂow cytometer (Becton Dickinson). The percentage viability
was calculated in comparison with the control culture. The
IC50 was calculated using linear regression analysis from the
Kc values of the concentrations employed.
2.4. In Vitro Activity Assay
2.4.1. Promastigote Forms, Assay. The compounds obtained
were dissolved in the culture medium, at dosages of 100,
50, 25, 10, and 1μM. The eﬀects of each compound against
promastigote formsweretestedat72 hoursusing a Neubauer
haemocytometric chamber. The antileishmanial eﬀect is
expressed as the IC50, that is, the concentration required to
give 50% inhibition, calculated by linear regression analysis
from the Kc values of the concentrations employed.
2.4.2. Amastigote Forms, Assay. J774.2 macrophages were
grown in minimum essential medium (MEM) plus glu-
tamine (2mM), supplemented with 20% inactive fetal
bovine serum, and were kept in a humidiﬁed atmosphere of
95% air and 5% CO2 at 37◦C.
Cells were seeded at a density of 1 × 104 cells/well in
24-well microplates (Nunc) with rounded coverslips on the
bottom and cultured for 2 days. Afterwards the cells were
infected in vitro with promastigote forms of L. infantum and
L. braziliensis, at a ratio of 10:1 during 24 hours. The non-
phagocytosed parasites were removed by washing, and then
thedrugs(at1,10,25,50,100μM)wereadded.Macrophages
with the drugs were incubated for 72 hours at 37◦Ci n5 %
CO2.
Drug activity was determined on the basis of number of
amastigotes in treated and untreated cultures in methanol-
ﬁxed and Giemsa-stained preparations. The number of
amastigotes was determined by analyzing 200 host cells
distributed in randomly chosen microscopic ﬁelds. The
antileishmanial eﬀect is expressed as the IC50 values are the
means of three separate determinations.
2.4.3. Axenic Amastigote Forms, Assay. Axenic amastigotes
forms of L. infantum and L. braziliensis were cultured
following the methodology described previously by Moreno
etal.[11].Thus,promastigotetransformationtoamastigotes
was obtained after three days of culture in M199 medium
(Invitrogen, Leiden, The Netherlands) supplemented with
10% heat-inactivated FCS, 1g/L β-alanine, 100mg/L L-
asparagine, 200mg/L sacarose, 50mg/L sodium pyruvate,
320mg/L malic acid, 40mg/L fumaric acid, 70mg/L succinic
acid, 200mg/L α-ketoglutaric acid, 300mg/L citric acid,
1.1g/L sodium bicarbonate, 5g/L MES, 0.4mg/L hemin,
and 10mg/L gentamicin pH 5.4 at 37◦C. The eﬀect of each
compound against axenic amastigotes forms was tested at
48 hours using a Neubauer haemocytometric chamber. The
antileishmanial eﬀect is expressed as the IC50.
2.5. Infection Assay. J774.2 macrophage cells were grown
under the same conditions expressed in amastigote forms
assay during two days. Afterwards, the cells were infected inThe Scientiﬁc World Journal 3
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(7) Petiolaroside (R1 = Glc, R3 = Rha, R2 = R5 = H, R4 = OH)
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Figure 1: Flavonoid compounds investigated.
vitrowithpromastigoteformsofL.infantumandL.brazilien-
sis,a tar a t i oo f1 0 : 1 .T h ed r u g s( I C 25 concentrations)
were added immediately after infection and were incubated
for 12 hours at 37◦Ci n5 %C O 2. The nonphagocytosed
parasites and the drugs were removed by washing, and
then the infected cultures were grown for 10 days in fresh
medium. Fresh culture medium was added every 48h.
The drug activity was determined from the percentage of
infected cells and the number of amastigotes per infected
cell (in treated and untreated cultures) in methanol-ﬁxed
and Giemsa-stained preparations. The percentageof infected
cells and the mean number of amastigotes per infected cell
were determined by analyzing 200 host cells distributed in
randomly chosen microscopic ﬁelds. Values are the average
of three separate determinations.
2.6. Metabolite Excretion. Cultures of L. infantum and L.
braziliensis promastigotes (initial concentration 5 × 105
cells/mL) received IC25 concentrations of the compounds
(except for control cultures). After incubation for 96 hours
at 28◦C, the cells were centrifuged at 400g for 10min.
Then supernatants were collected to determine the excreted
metabolites using 1H-NMR, and, eventually, chemical dis-
placements were expressed in parts per million (ppm),
using sodium 2,2-dimethyl-2-silapentane-5-sulphonate as
the reference signal. The chemical displacements used to
identify the respective metabolites wereconsistent with those
described by Fern´ andez-Becerra et al. [12]
2.7. Ultrastructural Alterations. The parasites were cultured
at a density of 5 × 105 cells/mL in MTL medium, and the
cultures contained drugs at the IC25 concentration.
After 96 hours, those cultures were centrifuged at 400g
for 10min, and the pellets produced were washed in PBS and
then mixed with 2% (v/v) P-formaldehyde-glutaraldehyde
in 0.05M cacodylate buﬀer (pH 7.4) for 4 hours at 4◦C.
After that, the pellets were prepared for TEM employing the
technique of Gonz´ alez et al. [4].
3. Results
3.1. In Vitro Antileishmanial Evaluation. The IC50 values
obtained on promastigote, axenic amastigote, and intracel-
lular amastigote forms of L. infantum and L. braziliensis after
72h of exposure with compounds 1–9 are displayed in the
ﬁrst three columns of Table 1. Values of the reference drug,
Glucantime, are also included for all cases for comparison.
The antileishmanial activity in both extra- and intracel-
lular forms is similar or, in most cases, less than that found
for Glucantime, with the compounds 7, 8,a n d9 presenting
the lowest IC50.
The macrophage toxicity of these compounds is of
particular interest as all compounds tested show signiﬁcantly
less toxicity to macrophages than the reference drug, from
15 to 65 times (Table 1). Thus, compounds 4, 5, 6, 7,a n d8
present IC50 values greater than 1000μM, while compounds
1, 2, 3,a n d9 give smaller IC50 values of 235.9μM, 267.0μM,
350.6μM, and 489.8μM, respectively.
Toxicity values substantially inﬂuence the more informa-
tive selectivity index data (SI, IC50 macrophage toxicity/IC50
activity of extracellular or intracellular forms of the parasite)
which are shown in the last three columns of Table 1.
The numbers of times that the compound SI exceeds the
Glucantime SI are given in brackets. These values are very4 The Scientiﬁc World Journal
T
a
b
l
e
1
:
I
n
v
i
t
r
o
a
c
t
i
v
i
t
y
,
t
o
x
i
c
i
t
y
,
a
n
d
s
e
l
e
c
t
i
v
i
t
y
i
n
d
e
x
f
o
u
n
d
f
o
r
t
h
e
a
s
t
r
a
g
a
l
i
n
-
b
a
s
e
d
(
1
–
3
)
,
p
a
e
o
n
o
s
i
d
e
-
b
a
s
e
d
(
4
–
6
)
,
a
n
d
p
e
t
i
o
l
a
r
o
s
i
d
e
-
b
a
s
e
d
(
7
–
9
)
d
e
r
i
v
a
t
i
v
e
s
o
n
e
x
t
r
a
c
e
l
l
u
l
a
r
a
n
d
i
n
t
r
a
c
e
l
l
u
l
a
r
f
o
r
m
s
o
f
L
e
i
s
h
m
a
n
i
a
s
p
p
.
(
a
)
L
e
i
s
h
m
a
n
i
a
i
n
f
a
n
t
u
m
C
o
m
p
o
u
n
d
s
A
c
t
i
v
i
t
y
I
C
5
0
(
μ
M
)
a
b
M
a
c
r
o
p
h
a
g
e
t
o
x
i
c
i
t
y
I
C
5
0
S
I
c
P
r
o
m
a
s
t
i
g
o
t
e
f
o
r
m
s
A
x
e
n
i
c
a
m
a
s
t
i
g
o
t
e
f
o
r
m
s
I
n
t
r
a
c
e
l
l
u
l
a
r
a
m
a
s
t
i
g
o
t
e
f
o
r
m
s
P
r
o
m
a
s
t
i
g
o
t
e
f
o
r
m
s
A
x
e
n
i
c
a
m
a
s
t
i
g
o
t
e
f
o
r
m
s
I
n
t
r
a
c
e
l
l
u
l
a
r
a
m
a
s
t
i
g
o
t
e
f
o
r
m
s
G
l
u
c
a
n
t
i
m
e
1
8
.
0
±
3
.
1
2
4
.
2
±
2
.
6
3
0
.
0
±
2
.
7
1
5
.
2
±
1
.
3
0
.
8
0
.
6
0
.
5
1
3
5
.
1
±
3
.
3
2
9
.
2
±
2
.
8
4
5
.
9
±
2
.
7
2
3
5
.
9
±
1
7
.
9
6
.
7
(
8
)
8
.
1
(
1
4
)
5
.
1
(
1
0
)
2
3
4
.
1
±
1
.
6
3
2
.
7
±
5
.
0
4
2
.
3
±
3
.
9
2
6
7
.
0
±
1
1
.
0
7
.
8
(
1
0
)
8
.
2
(
1
4
)
6
.
3
(
1
3
)
3
4
0
.
4
±
3
.
4
2
9
.
2
±
3
.
1
3
8
.
1
±
1
.
6
3
5
0
.
6
±
2
6
.
8
8
.
7
(
1
1
)
1
2
.
0
(
2
0
)
9
.
2
(
1
8
)
4
2
5
.
1
±
1
.
9
2
6
.
9
±
1
.
4
3
1
.
4
±
2
.
0
>
1
0
0
0
.
0
±
6
0
.
0
3
9
.
8
(
5
0
)
3
7
.
2
(
6
2
)
3
1
.
8
(
6
4
)
5
2
4
.
6
±
3
.
7
2
9
.
8
±
2
.
2
3
7
.
2
±
3
.
5
>
1
0
0
0
0
±
7
1
.
4
4
0
.
7
(
5
1
)
3
3
.
6
(
5
6
)
2
6
.
9
(
5
4
)
6
2
3
.
1
±
4
.
6
3
0
.
5
±
2
.
3
4
0
.
3
±
2
,
4
>
1
0
0
0
.
0
±
8
2
.
0
4
3
.
3
(
5
4
)
3
2
.
8
(
5
5
)
2
4
.
8
(
5
0
)
7
2
4
.
5
±
1
.
1
1
9
.
4
±
1
.
4
2
7
.
8
±
1
.
4
>
1
0
0
0
.
0
±
5
5
.
6
4
0
.
8
(
5
1
)
5
1
.
5
(
8
6
)
3
6
.
0
(
7
2
)
8
1
9
.
1
±
0
,
9
1
8
.
4
±
1
.
3
3
2
.
1
±
2
.
0
>
1
0
0
0
.
0
±
3
8
.
9
5
2
.
4
(
6
6
)
5
4
.
3
(
9
1
)
3
1
.
2
(
6
2
)
9
2
2
.
8
±
1
.
7
2
1
.
5
±
0
.
9
3
1
.
0
±
1
.
7
4
8
9
.
8
±
2
2
.
4
2
1
.
5
(
2
7
)
2
2
.
8
(
3
8
)
1
5
.
8
(
3
2
)
(
b
)
L
e
i
s
h
m
a
n
i
a
b
r
a
z
i
l
i
e
n
s
i
s
C
o
m
p
o
u
n
d
s
A
c
t
i
v
i
t
y
I
C
5
0
(
μ
M
)
a
b
M
a
c
r
o
p
h
a
g
e
t
o
x
i
c
i
t
y
I
C
5
0
S
I
c
P
r
o
m
a
s
t
i
g
o
t
e
f
o
r
m
s
A
x
e
n
i
c
a
m
a
s
t
i
g
o
t
e
f
o
r
m
s
I
n
t
r
a
c
e
l
l
u
l
a
r
a
m
a
s
t
i
g
o
t
e
f
o
r
m
s
P
r
o
m
a
s
t
i
g
o
t
e
f
o
r
m
s
A
x
e
n
i
c
a
m
a
s
t
i
g
o
t
e
f
o
r
m
s
I
n
t
r
a
c
e
l
l
u
l
a
r
a
m
a
s
t
i
g
o
t
e
f
o
r
m
s
G
l
u
c
a
n
t
i
m
e
2
5
.
6
±
1
.
6
3
0
.
4
±
6
.
1
3
1
.
1
±
3
.
0
1
5
.
2
±
1
.
3
0
.
6
0
.
5
0
,
5
1
2
8
.
1
±
1
.
0
2
2
.
6
±
1
.
7
3
2
.
2
±
1
.
6
2
3
5
.
9
±
1
7
.
9
8
.
4
(
1
4
)
1
0
.
4
(
2
1
)
7
.
3
(
1
5
)
2
2
5
.
1
±
2
.
5
2
7
.
9
±
2
.
7
3
0
.
2
±
3
.
8
2
6
7
.
0
±
1
1
.
0
1
0
.
6
(
1
8
)
9
.
6
(
1
9
)
8
.
8
(
1
8
)
3
2
8
.
4
±
3
.
0
3
2
.
9
±
3
.
0
4
1
.
9
±
4
.
0
3
5
0
.
6
±
2
6
.
8
1
2
.
3
(
2
1
)
1
0
.
7
(
2
1
)
8
.
4
(
1
7
)
4
2
8
.
1
±
5
.
2
2
3
.
7
±
2
.
1
3
2
.
7
±
2
.
1
>
1
0
0
0
.
0
±
6
0
.
0
3
5
.
6
(
5
9
)
4
2
.
2
(
8
4
)
3
0
.
6
(
6
1
)
5
3
4
.
1
±
6
.
6
1
9
.
4
±
0
.
9
5
0
.
9
±
6
.
2
>
1
0
0
0
.
0
±
7
1
.
4
2
9
.
3
(
4
9
)
5
1
.
5
(
1
0
3
)
2
0
.
0
(
4
0
)
6
3
1
.
3
±
3
.
0
2
8
.
0
±
1
.
6
3
0
.
4
±
2
.
7
>
1
0
0
0
.
0
±
8
2
.
0
3
1
.
9
(
5
3
)
3
5
.
7
(
7
1
)
3
2
.
9
(
6
6
)
7
2
1
.
1
±
1
.
7
1
9
.
5
±
0
.
8
3
3
.
9
±
3
.
5
>
1
0
0
0
.
0
±
5
5
.
6
4
7
.
4
(
7
9
)
5
1
.
3
(
1
0
3
)
2
9
.
5
(
5
9
)
8
2
9
.
0
±
1
.
5
2
5
.
5
±
0
.
7
2
0
.
1
±
1
.
7
>
1
0
0
0
.
0
±
3
8
.
9
3
4
.
5
(
5
8
)
3
9
.
2
(
7
8
)
4
9
.
8
(
1
0
0
)
9
3
2
.
3
±
3
.
3
2
4
.
6
±
1
.
3
2
1
.
0
±
1
.
3
4
8
9
.
8
±
2
2
.
4
1
5
.
2
(
2
5
)
1
9
.
9
(
4
0
)
2
3
.
3
(
4
7
)
R
e
s
u
l
t
s
a
r
e
a
v
e
r
a
g
e
s
o
f
t
h
r
e
e
s
e
p
a
r
a
t
e
d
e
t
e
r
m
i
n
a
t
i
o
n
s
.
a
I
C
5
0
=
t
h
e
c
o
n
c
e
n
t
r
a
t
i
o
n
r
e
q
u
i
r
e
d
t
o
g
i
v
e
5
0
%
i
n
h
i
b
i
t
i
o
n
,
c
a
l
c
u
l
a
t
e
d
b
y
l
i
n
e
a
r
r
e
g
r
e
s
s
i
o
n
a
n
a
l
y
s
i
s
f
r
o
m
t
h
e
K
c
v
a
l
u
e
s
a
t
c
o
n
c
e
n
t
r
a
t
i
o
n
s
e
m
p
l
o
y
e
d
(
1
,
1
0
,
2
5
,
5
0
,
a
n
d
1
0
0
μ
M
)
.
b
A
g
a
i
n
s
t
J
7
7
4
.
2
m
a
c
r
o
p
h
a
g
e
s
a
f
t
e
r
7
2
h
o
f
c
u
l
t
u
r
e
.
c
S
e
l
e
c
t
i
v
i
t
y
i
n
d
e
x
=
I
C
5
0
m
a
c
r
o
p
h
a
g
e
s
/
I
C
5
0
e
x
t
r
a
c
e
l
l
u
l
a
r
a
n
d
i
n
t
r
a
c
e
l
l
u
l
a
r
f
o
r
m
o
f
t
h
e
p
a
r
a
s
i
t
e
.
I
n
b
r
a
c
k
e
t
s
:
n
u
m
b
e
r
o
f
t
i
m
e
s
t
h
a
t
c
o
m
p
o
u
n
d
S
I
e
x
c
e
e
d
s
t
h
e
r
e
f
e
r
e
n
c
e
d
r
u
g
S
I
.The Scientiﬁc World Journal 5
I
n
f
e
c
t
i
o
n
 
(
%
)
80
64
48
32
16
0
0123456789 1 0
Time (days)
(a)
I
n
f
e
c
t
i
o
n
 
(
%
)
80
64
48
32
16
0
0123456789 1 0
Time (days)
(b)
N
u
m
b
e
r
 
o
f
 
a
m
a
s
t
i
g
o
t
e
/
m
a
c
r
o
p
h
a
g
e
50
40
30
20
10
0
0123456789 1 0
Time (days)
(c)
N
u
m
b
e
r
 
o
f
 
a
m
a
s
t
i
g
o
t
e
/
m
a
c
r
o
p
h
a
g
e
70
56
42
28
14
0
0123456789 1 0
Time (days)
(d)
Figure 2: Eﬀects of ﬂavonoids 4, 5, 6, 7,a n d8 on the infection and growth rates of Leishmania spp. (a) rate of infection of L. infantum;( c )
mean number of amastigotes per infected J774 A.2 macrophage cells of L. infantum; (b) rate of infection of L. braziliensis; (d) mean number
of amastigotes per infected J774 A.2 macrophage cells of L. braziliensis.( -  -, control; - -, comp. 4;-  -, comp. 5;-  -, comp. 6;- ♦-, comp.
7;- ∇-, comp. 8;-  -, Glucantime). At IC25 conc., values are means of three separate experiments.
illustrative of the in vitro potential of the compounds tested
with respect to the reference drug. Compounds 7, 8, 4, 5,
and 6 showed the best SI for L. infantum (Table 1(a)), with
indexes exceeding that of the reference drug SI by more than
50 times. Compounds 1, 2, 3,a n d9 were more eﬀective than
Glucantime; however, SI values of 50 times or greater were
not reached, which is the criterion for a compound to be
included in subsequent studies [13].
Similar results can be extracted from the L. braziliensis
data shown in Table 1(b). The compounds 7, 8, 4,a n d6
again gave the best SI results in the three assays performed,
with values exceeding those of the reference drugs by 79,
103, and 59 times in the case of compound 7, by 58, 78,
and 100 times for compound 8, by 59, 84, and 61 times for
compound 4, and by 53, 71, and 66 times for compound 6.
Although compound 5 did not give SI values greater than
or equal to 50 times those of the reference drugs, it was
included in subsequent studies because promastigote and
intracellular amastigote SI values were close to 50 times that
of the reference drug, while the axenic amastigote SI was two
times (Table 1(b)).
The eﬀectiveness of the compounds on the infection rate
and the intracellular replication of the amastigote forms was
determined by the infection assay (Figure 2). When selected
ﬂavonoid compounds 4–8 and Glucantime were added at
their respective IC25 concentrations to macrophages infected
with Leishmania spp. promastigote forms, the infection
rate decreased signiﬁcantly after 12h with respect to the
control measurement. The infection rate decreases followed
the trend 8 > 5 > 7 = 4 > 6 for L. infantum (Figure 2(a))
and 8>6>5>7>4 for L. braziliensis (Figure 2(b))w i t h
percentages of inhibition capacity of 95%, 79%, 77%, and
71%, respectively, in the case of L. infantum and 88%,
82%, 79%, 69%, and 68%, respectively, in the case of L.
braziliensis. These values are remarkably higher than those
for inhibition by Glucantime (63% and 58% for L. infantum
and L. braziliensis, resp.).6 The Scientiﬁc World Journal
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Figure 3: Variation in the height of the peaks corresponding to catabolites excreted by L. infantum (a) and L. braziliensis (b) promastigote
forms in the presence of ﬂavonoid derivatives with respect to the control test.
All ﬁve compounds were more eﬀective than Glucantime
(only 12% decrease for L. infantum and 33% decrease
for L. braziliensis) at decreasing the average number of
amastigotes per infected macrophage cells (Figures 2(c) and
2(d)).Compound8wasthemosteﬀectiveinL.infantumand
L. braziliensis. The amastigote number decreases measured
were as follows: 8 (78%) > 7 (49%) > 5(45%) > 4 (37%) > 6
(24%) for L. infantum and 8 (82%) > 5 (72%) > 6 (69%) > 4
(61%) > 7 (55%) for L. braziliensis.
3.2. Metabolites Excretion Eﬀect. After treatment of the
parasites with compounds 4–8 at IC25, the excretion of
the catabolites was clearly altered. Figure 3 displays the
modiﬁcations observed in the height of the spectra peaks
corresponding to the most representative ﬁnal excretion
products. From a careful examination of the data, it would
appear that there are marked diﬀerences in the catabolic
pathway. In the case of L. infantum, compounds 4, 5, 6,a n d
8 gave similar spectra, with an increase in the excretion of
succinate, and acetate, followed by malate, alanine, lactate
and ethanol. On the other hand, compound 7 causes an
increase in the production of malate, succinate, ethanol, and
lactate, but a decrease of excreted acetate and alanine levels
(Figure 3(a)).
In the case of L. braziliensis, the increase of excreted
succinate was the most signiﬁcant change when the parasites
were treated with the compounds. Compounds 6, 7,a n d8
caused decreases in the excretion of acetate (Figure 3(b)).
3.3. Ultrastructural Alterations. The transmission electron
microscope evaluation of ﬂavonoid compounds 4–8 against
Leishmania spp. promastigotes showed notable ultrastruc-
tural alterations, as reﬂected in Figures 4 and 5 (panels b, c,
d, e) with respect to the control (Figures 4(a) and 5(a)). All
compounds produced signiﬁcant alterations to L. infantum,
but the compounds most eﬀective were4 and 8,a si ll u s tra t e d
in Figures 4(b) and 4(e). All of the compounds induced the
formation of strongly electrodense inclusions that appeared
inside and outside vacuoles with diﬀerent sizes, or directly in
the cell cytoplasm. The major eﬀect of compound 8 was that
manyoftheparasitesadopteddistortedshapeswithdistorted
cytoplasm, while no cytoplasmic organelles were visible
due to the altered appearance of promastigotes. However,
large vacuoles containing cellular debris were visible. With
compound 4 (Figure 4(b)), many of the parasites appeared
dead, while another showed pronounced vacuolization,
and many of these vacuoles contained strongly electro-
dense inclusions. Compound 5 produced similar eﬀects
(Figure 4(c)). In the same way, compound 6 induced empty
vacuoles, lipid vacuoles, and a large number of electrodense
vesicles (Figure 4(d)). By contrast, compound 7 showed no
induction of substantial alterations (graph not shown).
Studies of ultrastructural alterations made on L.
braziliensis showed that the compounds produced changes
similar to those they produced in L. infantum. Another eﬀect
of the compounds was the expansion of the kinetoplast,
which appeared swollen when treated with compound 4
(Figure 5(b)).Compound8(Figure 5(e))inducedchangesin
the shape of parasites, with them showing completely altered
forms. All these changes occurred after treatment with
compound 7 (Figure 5(d)), while compound 5 produced
no signiﬁcant changes compared to the control (data not
shown).
4. Discussion
Many people living in rural areas have no easy access to
conventional allopathic treatments, largely due to the limitedThe Scientiﬁc World Journal 7
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Figure 4: Ultrastructural alterations by TEM in L. infantum treated with the ﬂavonoid derivatives. (a) Control parasite of L. infantum
showing organelles with their characteristic features such as the nucleus (N), kinetoplast (K), reservosomes (R), mitochondrion (M), and
vacuoles(V)(bar:1μm).(b)L.infantumtreatedwithcompound4.Electrodenseorganelles(arrow)(Bar:1μm).(c)L.infantumtreatedwith
compound 5 with intense vacuolization (V) (Bar: 1.59μm). (d) L. infantum treated with compound 6, vacuoles (V), lipid vacuoles (LV),
and electrodense vesicles (arrow) (bar: 1.59μm). (e) L. infantum treated with compound 8 with distorted parasites (arrow) (Bar: 1μm).8 The Scientiﬁc World Journal
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Figure 5: Ultrastructural alterations by TEM in L. braziliensis treated with ﬂavonoid derivatives. (a) Control parasite of L. braziliensis with
structures such as the nucleus (N), reservosomes (R), vacuoles (V), and mitochondrion (M) (bar: 1μm). (b) L. braziliensis treated with
compound 4 with vacuoles (V) and swelling kinetoplast (arrow) (bar: 1μm). (c) L. braziliensis treated with compound 6 (bar: 1.59μm). (d)
L. braziliensis treated with compound 7 with intense vacuolization (V), electrodense organelles (arrow), and swelling kinetoplast (K) (bar:
2.33μm). (e) L. braziliensis treated with compound 8 with distorted forms (bar: 1.59μm).
availability of health services and their low socioeconomic
status. Therefore, plants may provide an important and nec-
essary source of therapeutic medicinal compounds. Flavones
and their derivatives, ﬂavonoids and ﬂavonols, are among
the most attractive plant derivatives that might enrich the
current therapy options, due to their extremely large range
of biological properties [14].
In this study, in vitro biological activity of nine ﬂavonoid
compounds against extracellular and intracellular forms
Leishmania spp. was investigated. This is important as manyThe Scientiﬁc World Journal 9
studies of the activity of compounds against Leishmania
spp. are performed on promastigote forms, which are much
easier to work in vitro. However, since extracellular forms are
not the developed forms of the parasite in vertebrate hosts,
evaluations made with these forms are merely indicative
of the potential leishmanicidal activity of the compounds
tested. Consequently, a preliminary test using extracellular
promastigote forms should always be complemented by a
subsequentevaluationusingintracellularforms(amastigotes
in vertebrate host cells), so that a better understanding of the
activity may be obtained [4].
The petiolaroside-based derivatives (7–9) presented the
lowest IC50values against extra- and intracellular forms.
Previously, the nine ﬂavonoids investigated here were
tested against epimastigote forms of Trypanosoma cruzi,a n d
the most eﬀective compounds were astragalin (1) and two
acetylatedderivatives(2and3).Thesehadsigniﬁcantlylower
IC50 valuescomparedwithbenznidazole [15]. Bycontrast,in
this study, we saw that the astragalin and its derivates were
the least eﬀective agents against Leishmania spp.
Petiolaroside, 2  -acetylpetiolaroside (7 and 8,r e s p . ) ,a n d
paeonoside and its derivates (4, 5, and 6) showed the best
selectivityindexes.Theseindexesexceededthereferencedrug
SI by more than 50 times. The astragalin and its derivates
(1, 2, and 3) and petiolaroside decacetate (9)w e r ea l lm o r e
eﬀective than Glucantime.
If we compare the results obtained for the infection rate
and the number of amastigotes per infected macrophage
cells for both Leishmania species, it can be concluded that
2  -acetylpetiolaroside (8) is clearly the most active. The
acetylated derivatives 2  -acetylpetiolaroside (8)a n d2   -
acetylpaeonoside (5) are more active than petiolaroside (7)
and paeonoside (4), respectively.
As far as is known to date, none of the trypanosomatids
studied are capable of completely degrading glucose to CO2
under aerobic conditions. When this occurs, it results in the
excretion of a major part of the carbon skeleton into the
medium as fermented metabolites, which can diﬀer accord-
ing to the employed species [16]. 1H-NMR spectra enabled
us to determine the fermented metabolites excreted by the
parasites during their in vitro culture. The ﬁnal products of
glucose catabolism in Leishmania are usually CO2, succinate,
acetate, L-lactate, pyruvate, L-alanine, and ethanol [17]. As
with T. cruzi [18], one of the major metabolites excreted by
Leishmania spp. is succinate, with the main role likely to
be to maintain the glycosomal redox balance by providing
two glycosomal oxidoreductase enzymes. These enzymes
allow reoxidation of NADH produced by glyceraldehyde-3-
phosphate dehydrogenase in the glycolytic pathway. Succinic
fermentation oﬀers one signiﬁcant advantage as it requires
only half the produced phosphoenolpyruvate (PEP) to
maintain the NAD+/NADH balance. The remaining PEP
is converted to acetate, depending on the species under
consideration.
The majority of metabolites excreted by L. infantum are
succinate and acetate. In the case of L. infantum, variations
in the ﬁnal catabolism products seem to be dependent on
the structural aspects of the compounds assayed. These data
agree well with those of other authors [18].
Analyses of in vitro and in vivo results of Trypanosoma
cruzi showed that the best potential ﬂavonoids to treat
Chagas disease were the acetylated compounds 2, 5,a n d6
[15]. The present work conﬁrmed this conclusion in the case
of visceral leishmaniasis (L. infantum) and mucocutaneous
leishmaniasis (L. braziliensis). Moreover, these data are
consistent with others previously published, which showed
that several acetylated ﬂavonoids derived from Consolida
oliveriana were very active in vitro against both extracellular
and intracellular forms of L. (V.) peruviana and L. (V.)
braziliensis [9].
Inconclusion,thisstudyhasdemonstratedthatﬂavonoid
derivatives are active against L. infantum and L. braziliensis.
These results support further investigation of ﬂavonoid
compounds as potential agents against Leishmaniasis.
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